首页 > 最新文献

EcoSal Plus最新文献

英文 中文
The EcoCyc database (2025). EcoCyc数据库(2025)。
Q1 Medicine Pub Date : 2025-04-30 DOI: 10.1128/ecosalplus.esp-0019-2024
Peter D Karp, Suzanne Paley, Ron Caspi, Anamika Kothari, Markus Krummenacker, Peter E Midford, Lisa R Moore, Pallavi Subhraveti, Socorro Gama-Castro, Víctor H Tierrafria, Paloma Lara, Luis Muñiz-Rascado, César Bonavides-Martinez, Alberto Santos-Zavaleta, Amanda Mackie, Gwanggyu Sun, Travis A Ahn-Horst, Heejo Choi, Riley Juenemann, Cyrus N M Knudsen, Markus W Covert, Julio Collado-Vides, Ian Paulsen

EcoCyc is a bioinformatics database (DB) available at EcoCyc.org that describes the genome and the biochemical machinery of Escherichia coli K-12 MG1655. The long-term goal of the project was to describe the complete molecular catalog of the E. coli cell, as well as the functions of each of its molecular parts, to facilitate a system-level understanding of E. coli. EcoCyc is an electronic reference source for E. coli biologists and for biologists who work with related microorganisms. The database includes information pages on each E. coli gene product, metabolite, reaction, operon, and metabolic pathway. The database also includes information on the regulation of gene expression, E. coli gene essentiality, and nutrient conditions that do or do not support the growth of E. coli. The website and downloadable software contain tools for the analysis of high-throughput data sets. In addition, a steady-state metabolic flux model is generated from each new version of EcoCyc and can be executed via EcoCyc.org. The model can predict metabolic flux rates, nutrient uptake rates, and growth rates for different gene knockouts and nutrient conditions. Data generated from a whole-cell model that is parameterized from the latest data on EcoCyc is also available. This review outlines the data content of EcoCyc and the procedures by which this content is generated.

EcoCyc是一个生物信息学数据库(DB),描述了大肠杆菌K-12 MG1655的基因组和生化机制。该项目的长期目标是描述大肠杆菌细胞的完整分子目录,以及其每个分子部分的功能,以促进对大肠杆菌的系统级理解。EcoCyc是大肠杆菌生物学家和从事相关微生物工作的生物学家的电子参考源。该数据库包括每个大肠杆菌基因产物、代谢物、反应、操纵子和代谢途径的信息页面。该数据库还包括基因表达调控、大肠杆菌基因的重要性以及支持或不支持大肠杆菌生长的营养条件的信息。该网站和可下载的软件包含用于分析高通量数据集的工具。此外,每个新版本的EcoCyc都会生成稳态代谢通量模型,并可通过EcoCyc.org执行。该模型可以预测不同基因敲除和营养条件下的代谢通量率、营养摄取率和生长率。从EcoCyc上的最新数据参数化的全细胞模型生成的数据也可用。本综述概述了EcoCyc的数据内容以及生成这些内容的程序。
{"title":"The EcoCyc database (2025).","authors":"Peter D Karp, Suzanne Paley, Ron Caspi, Anamika Kothari, Markus Krummenacker, Peter E Midford, Lisa R Moore, Pallavi Subhraveti, Socorro Gama-Castro, Víctor H Tierrafria, Paloma Lara, Luis Muñiz-Rascado, César Bonavides-Martinez, Alberto Santos-Zavaleta, Amanda Mackie, Gwanggyu Sun, Travis A Ahn-Horst, Heejo Choi, Riley Juenemann, Cyrus N M Knudsen, Markus W Covert, Julio Collado-Vides, Ian Paulsen","doi":"10.1128/ecosalplus.esp-0019-2024","DOIUrl":"10.1128/ecosalplus.esp-0019-2024","url":null,"abstract":"<p><p>EcoCyc is a bioinformatics database (DB) available at EcoCyc.org that describes the genome and the biochemical machinery of <i>Escherichia coli</i> K-12 MG1655. The long-term goal of the project was to describe the complete molecular catalog of the <i>E. coli</i> cell, as well as the functions of each of its molecular parts, to facilitate a system-level understanding of <i>E. coli</i>. EcoCyc is an electronic reference source for <i>E. coli</i> biologists and for biologists who work with related microorganisms. The database includes information pages on each <i>E. coli</i> gene product, metabolite, reaction, operon, and metabolic pathway. The database also includes information on the regulation of gene expression, <i>E. coli</i> gene essentiality, and nutrient conditions that do or do not support the growth of <i>E. coli</i>. The website and downloadable software contain tools for the analysis of high-throughput data sets. In addition, a steady-state metabolic flux model is generated from each new version of EcoCyc and can be executed via EcoCyc.org. The model can predict metabolic flux rates, nutrient uptake rates, and growth rates for different gene knockouts and nutrient conditions. Data generated from a whole-cell model that is parameterized from the latest data on EcoCyc is also available. This review outlines the data content of EcoCyc and the procedures by which this content is generated.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00192024"},"PeriodicalIF":0.0,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The E. coli CRISPR-Cas conundrum: are they functional immune systems or genomic singularities? 大肠杆菌CRISPR-Cas难题:它们是功能性免疫系统还是基因组奇点?
Q1 Medicine Pub Date : 2025-04-09 DOI: 10.1128/ecosalplus.esp-0040-2020
Edward G Dudley

The discovery and subsequent characterization and applications of CRISPR-Cas is one of the most fascinating scientific stories from the past two decades. While first identified in Escherichia coli, this microbial workhorse often took a back seat to other bacteria during the early race to detail CRISPR-Cas function as an adaptive immune system. This was not a deliberate slight, but the result of early observations that the CRISPR-Cas systems found in E. coli were not robust phage defense systems as first described in Streptococcus thermophilus. This apparent lack of activity was discovered to result from transcriptional repression by the nucleoid protein H-NS. Despite extensive evidence arguing against such roles, some studies still present E. coli CRISPR-Cas systems in the context of anti-phage and/or anti-plasmid activities. Here, the studies that led to our understanding of its cryptic nature are highlighted, along with ongoing research to uncover potential alternative functions in E. coli.

CRISPR-Cas的发现和随后的表征和应用是过去二十年来最引人入胜的科学故事之一。虽然最初是在大肠杆菌中发现的,但在早期的竞争中,这种微生物的主力经常让位于其他细菌,以详细描述CRISPR-Cas作为适应性免疫系统的功能。这并不是故意的轻视,而是早期观察的结果,即在大肠杆菌中发现的CRISPR-Cas系统并不像最初在嗜热链球菌中描述的那样是强大的噬菌体防御系统。发现这种明显缺乏活性是由于类核蛋白H-NS的转录抑制所致。尽管有大量证据反对这种作用,但一些研究仍然在抗噬菌体和/或抗质粒活性的背景下提出了大肠杆菌CRISPR-Cas系统。在这里,我们重点介绍了使我们了解其隐性的研究,以及正在进行的揭示大肠杆菌潜在替代功能的研究。
{"title":"The <i>E. coli</i> CRISPR-Cas conundrum: are they functional immune systems or genomic singularities?","authors":"Edward G Dudley","doi":"10.1128/ecosalplus.esp-0040-2020","DOIUrl":"https://doi.org/10.1128/ecosalplus.esp-0040-2020","url":null,"abstract":"<p><p>The discovery and subsequent characterization and applications of CRISPR-Cas is one of the most fascinating scientific stories from the past two decades. While first identified in <i>Escherichia coli</i>, this microbial workhorse often took a back seat to other bacteria during the early race to detail CRISPR-Cas function as an adaptive immune system. This was not a deliberate slight, but the result of early observations that the CRISPR-Cas systems found in <i>E. coli</i> were not robust phage defense systems as first described in <i>Streptococcus thermophilus</i>. This apparent lack of activity was discovered to result from transcriptional repression by the nucleoid protein H-NS. Despite extensive evidence arguing against such roles, some studies still present <i>E. coli</i> CRISPR-Cas systems in the context of anti-phage and/or anti-plasmid activities. Here, the studies that led to our understanding of its cryptic nature are highlighted, along with ongoing research to uncover potential alternative functions in <i>E. coli</i>.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00402020"},"PeriodicalIF":0.0,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143810786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Siderophore cephalosporins. 含铁细胞头孢菌素。
Q1 Medicine Pub Date : 2025-04-07 DOI: 10.1128/ecosalplus.esp-0015-2022
Malcolm G P Page

Siderophore cephalosporins are designed to exploit bacterial nutrient uptake systems to gain accelerated uptake across the outer membrane of Gram-negative bacteria. They contain iron (III) binding motifs that allow them to form complexes that will be recognized as potential substrates by iron-siderophore transport systems. Research during the last five decades has culminated in the approval for clinical use of the siderophore cephalosporin cefiderocol, which incorporates accumulated learning from investigations of structural features that enhance resistance toward hydrolysis by β-lactamases, that promote bacterial membrane permeability, and that confer long pharmacokinetic half-life in the human host.

铁载体类头孢菌素被设计为利用细菌营养吸收系统来加速吸收革兰氏阴性菌的外膜。它们含有铁(III)结合基元,使它们能够形成配合物,这些配合物将被铁铁载体运输系统识别为潜在的底物。过去50年的研究最终批准了铁载体头孢菌素cefiderocol的临床应用,该研究结合了从结构特征研究中积累的知识,这些结构特征增强了对β-内酰胺酶水解的抵抗力,促进了细菌膜的通透性,并赋予了人类宿主较长的药代动力学半衰期。
{"title":"Siderophore cephalosporins.","authors":"Malcolm G P Page","doi":"10.1128/ecosalplus.esp-0015-2022","DOIUrl":"https://doi.org/10.1128/ecosalplus.esp-0015-2022","url":null,"abstract":"<p><p>Siderophore cephalosporins are designed to exploit bacterial nutrient uptake systems to gain accelerated uptake across the outer membrane of Gram-negative bacteria. They contain iron (III) binding motifs that allow them to form complexes that will be recognized as potential substrates by iron-siderophore transport systems. Research during the last five decades has culminated in the approval for clinical use of the siderophore cephalosporin cefiderocol, which incorporates accumulated learning from investigations of structural features that enhance resistance toward hydrolysis by β-lactamases, that promote bacterial membrane permeability, and that confer long pharmacokinetic half-life in the human host.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00152022"},"PeriodicalIF":0.0,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatio-temporal organization of the E. coli chromosome from base to cellular length scales. 从碱基到细胞长度尺度的大肠杆菌染色体时空组织。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-06-12 DOI: 10.1128/ecosalplus.esp-0001-2022
Sonya K Royzenblat, Lydia Freddolino

Escherichia coli has been a vital model organism for studying chromosomal structure, thanks, in part, to its small and circular genome (4.6 million base pairs) and well-characterized biochemical pathways. Over the last several decades, we have made considerable progress in understanding the intricacies of the structure and subsequent function of the E. coli nucleoid. At the smallest scale, DNA, with no physical constraints, takes on a shape reminiscent of a randomly twisted cable, forming mostly random coils but partly affected by its stiffness. This ball-of-spaghetti-like shape forms a structure several times too large to fit into the cell. Once the physiological constraints of the cell are added, the DNA takes on overtwisted (negatively supercoiled) structures, which are shaped by an intricate interplay of many proteins carrying out essential biological processes. At shorter length scales (up to about 1 kb), nucleoid-associated proteins organize and condense the chromosome by inducing loops, bends, and forming bridges. Zooming out further and including cellular processes, topological domains are formed, which are flanked by supercoiling barriers. At the megabase-scale both large, highly self-interacting regions (macrodomains) and strong contacts between distant but co-regulated genes have been observed. At the largest scale, the nucleoid forms a helical ellipsoid. In this review, we will explore the history and recent advances that pave the way for a better understanding of E. coli chromosome organization and structure, discussing the cellular processes that drive changes in DNA shape, and what contributes to compaction and formation of dynamic structures, and in turn how bacterial chromatin affects key processes such as transcription and replication.

大肠杆菌一直是研究染色体结构的重要模式生物,这部分归功于它的小而圆的基因组(460 万碱基对)和特征良好的生化途径。过去几十年来,我们在了解大肠杆菌核团结构及其功能方面取得了长足的进步。在最小尺度上,DNA 在没有物理约束的情况下,其形状让人联想到随机扭曲的电缆,形成的线圈大部分是随机的,但部分受到其硬度的影响。这种面条球状的形状形成了一个大数倍的结构,无法装入细胞。一旦加上细胞的生理限制,DNA 就会形成过度扭曲(负超卷)的结构,这种结构是由许多执行重要生物过程的蛋白质错综复杂地相互作用形成的。在较短的长度范围内(最多约 1 kb),核团相关蛋白通过诱导环、弯曲和形成桥来组织和凝结染色体。进一步放大,包括细胞过程在内,拓扑结构域形成,其两侧是超卷曲屏障。在巨碱基尺度上,既观察到了大型、高度自我相互作用的区域(宏域),也观察到了相距遥远但共同调控的基因之间的强烈接触。在最大尺度上,核团形成一个螺旋椭圆体。在这篇综述中,我们将探讨为更好地了解大肠杆菌染色体组织和结构铺平道路的历史和最新进展,讨论驱动 DNA 形状变化的细胞过程、促成压实和动态结构形成的因素,以及细菌染色质如何反过来影响转录和复制等关键过程。
{"title":"Spatio-temporal organization of the <i>E. coli</i> chromosome from base to cellular length scales.","authors":"Sonya K Royzenblat, Lydia Freddolino","doi":"10.1128/ecosalplus.esp-0001-2022","DOIUrl":"10.1128/ecosalplus.esp-0001-2022","url":null,"abstract":"<p><p><i>Escherichia coli</i> has been a vital model organism for studying chromosomal structure, thanks, in part, to its small and circular genome (4.6 million base pairs) and well-characterized biochemical pathways. Over the last several decades, we have made considerable progress in understanding the intricacies of the structure and subsequent function of the <i>E. coli</i> nucleoid. At the smallest scale, DNA, with no physical constraints, takes on a shape reminiscent of a randomly twisted cable, forming mostly random coils but partly affected by its stiffness. This ball-of-spaghetti-like shape forms a structure several times too large to fit into the cell. Once the physiological constraints of the cell are added, the DNA takes on overtwisted (negatively supercoiled) structures, which are shaped by an intricate interplay of many proteins carrying out essential biological processes. At shorter length scales (up to about 1 kb), nucleoid-associated proteins organize and condense the chromosome by inducing loops, bends, and forming bridges. Zooming out further and including cellular processes, topological domains are formed, which are flanked by supercoiling barriers. At the megabase-scale both large, highly self-interacting regions (macrodomains) and strong contacts between distant but co-regulated genes have been observed. At the largest scale, the nucleoid forms a helical ellipsoid. In this review, we will explore the history and recent advances that pave the way for a better understanding of <i>E. coli</i> chromosome organization and structure, discussing the cellular processes that drive changes in DNA shape, and what contributes to compaction and formation of dynamic structures, and in turn how bacterial chromatin affects key processes such as transcription and replication.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00012022"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic engineering of Salmonella spp. for novel vaccine strategies and therapeutics. 用于新型疫苗战略和治疗的沙门氏菌属基因工程。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-07-18 DOI: 10.1128/ecosalplus.esp-0004-2023
Garima Bansal, Mostafa Ghanem, Khandra T Sears, James E Galen, Sharon M Tennant

Salmonella enterica is a diverse species that infects both humans and animals. S. enterica subspecies enterica consists of more than 1,500 serovars. Unlike typhoidal Salmonella serovars which are human host-restricted, non-typhoidal Salmonella (NTS) serovars are associated with foodborne illnesses worldwide and are transmitted via the food chain. Additionally, NTS serovars can cause disease in livestock animals causing significant economic losses. Salmonella is a well-studied model organism that is easy to manipulate and evaluate in animal models of infection. Advances in genetic engineering approaches in recent years have led to the development of Salmonella vaccines for both humans and animals. In this review, we focus on current progress of recombinant live-attenuated Salmonella vaccines, their use as a source of antigens for parenteral vaccines, their use as live-vector vaccines to deliver foreign antigens, and their use as therapeutic cancer vaccines in humans. We also describe development of live-attenuated Salmonella vaccines and live-vector vaccines for use in animals.

肠炎沙门氏菌种类繁多,可感染人类和动物。肠炎沙门氏菌亚种由 1 500 多个血清型组成。伤寒型沙门氏菌血清对人类宿主有限制,而非伤寒型沙门氏菌(NTS)血清则与世界各地的食源性疾病有关,并通过食物链传播。此外,非伤寒沙门氏菌(NTS)血清型还可导致家畜患病,造成重大经济损失。沙门氏菌是一种经过充分研究的模式生物,易于在动物感染模型中进行操作和评估。近年来,基因工程方法的进步促进了人类和动物沙门氏菌疫苗的开发。在这篇综述中,我们将重点介绍重组减毒沙门氏菌活疫苗的最新进展、其作为肠外疫苗抗原来源的用途、其作为活载体疫苗传递外来抗原的用途,以及其作为人类治疗性癌症疫苗的用途。我们还介绍了用于动物的沙门氏菌减毒活疫苗和活载体疫苗的开发情况。
{"title":"Genetic engineering of <i>Salmonella</i> spp. for novel vaccine strategies and therapeutics.","authors":"Garima Bansal, Mostafa Ghanem, Khandra T Sears, James E Galen, Sharon M Tennant","doi":"10.1128/ecosalplus.esp-0004-2023","DOIUrl":"10.1128/ecosalplus.esp-0004-2023","url":null,"abstract":"<p><p><i>Salmonella enterica</i> is a diverse species that infects both humans and animals. <i>S. enterica</i> subspecies <i>enterica</i> consists of more than 1,500 serovars. Unlike typhoidal <i>Salmonella</i> serovars which are human host-restricted, non-typhoidal <i>Salmonella</i> (NTS) serovars are associated with foodborne illnesses worldwide and are transmitted via the food chain. Additionally, NTS serovars can cause disease in livestock animals causing significant economic losses. <i>Salmonella</i> is a well-studied model organism that is easy to manipulate and evaluate in animal models of infection. Advances in genetic engineering approaches in recent years have led to the development of <i>Salmonella</i> vaccines for both humans and animals. In this review, we focus on current progress of recombinant live-attenuated <i>Salmonella</i> vaccines, their use as a source of antigens for parenteral vaccines, their use as live-vector vaccines to deliver foreign antigens, and their use as therapeutic cancer vaccines in humans. We also describe development of live-attenuated <i>Salmonella</i> vaccines and live-vector vaccines for use in animals.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00042023"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type IV pili of Enterobacteriaceae species. 肠杆菌科物种的 IV 型纤毛虫。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-01-31 DOI: 10.1128/ecosalplus.esp-0003-2023
Janay I Little, Pradip K Singh, Jinlei Zhao, Shakeera Dunn, Hanover Matz, Michael S Donnenberg

Type IV pili (T4Ps) are surface filaments widely distributed among bacteria and archaea. T4Ps are involved in many cellular functions and contribute to virulence in some species of bacteria. Due to the diversity of T4Ps, different properties have been observed for homologous proteins that make up T4Ps in various organisms. In this review, we highlight the essential components of T4Ps, their functions, and similarities to related systems. We emphasize the unique T4Ps of enteric pathogens within the Enterobacteriaceae family, which includes pathogenic strains of Escherichia coli and Salmonella. These include the bundle-forming pilus (BFP) of enteropathogenic E. coli (EPEC), longus (Lng) and colonization factor III (CFA/III) of enterotoxigenic E. coli (ETEC), T4P of Salmonella enterica serovar Typhi, Colonization Factor Citrobacter (CFC) of Citrobacter rodentium, T4P of Yersinia pseudotuberculosis, a ubiquitous T4P that was characterized in enterohemorrhagic E. coli (EHEC), and the R64 plasmid thin pilus. Finally, we highlight areas for further study.

第四型纤毛(T4Ps)是广泛分布于细菌和古细菌中的表面丝状物。T4Ps 参与了许多细胞功能,并对某些种类细菌的毒力有影响。由于 T4Ps 的多样性,在不同生物体中组成 T4Ps 的同源蛋白也具有不同的特性。在本综述中,我们将重点介绍 T4Ps 的基本成分、功能以及与相关系统的相似性。我们强调肠杆菌科肠道病原体(包括大肠杆菌和沙门氏菌的致病菌株)特有的 T4Ps。这些T4Ps包括肠致病性大肠杆菌(EPEC)的成束柔毛(BFP)、肠致病性大肠杆菌(ETEC)的长柔毛(Lng)和定植因子III(CFA/III)、肠致病性大肠杆菌(EPEC)和沙门氏菌(Salmonella)的T4Ps。大肠杆菌(ETEC)的 T4P、伤寒沙门氏菌(Salmonella enterica serovar Typhi)的 T4P、枸橼酸杆菌(Citrobacter rodentium)的定植因子(CFC)、耶尔森氏菌(Yersinia pseudotuberculosis)的 T4P、肠出血性大肠杆菌(EHEC)中的一种无处不在的 T4P 以及 R64 质粒细螺旋体。最后,我们强调了有待进一步研究的领域。
{"title":"Type IV pili of <i>Enterobacteriaceae</i> species.","authors":"Janay I Little, Pradip K Singh, Jinlei Zhao, Shakeera Dunn, Hanover Matz, Michael S Donnenberg","doi":"10.1128/ecosalplus.esp-0003-2023","DOIUrl":"10.1128/ecosalplus.esp-0003-2023","url":null,"abstract":"<p><p>Type IV pili (T4Ps) are surface filaments widely distributed among bacteria and archaea. T4Ps are involved in many cellular functions and contribute to virulence in some species of bacteria. Due to the diversity of T4Ps, different properties have been observed for homologous proteins that make up T4Ps in various organisms. In this review, we highlight the essential components of T4Ps, their functions, and similarities to related systems. We emphasize the unique T4Ps of enteric pathogens within the <i>Enterobacteriaceae</i> family, which includes pathogenic strains of <i>Escherichia coli</i> and <i>Salmonella</i>. These include the bundle-forming pilus (BFP) of enteropathogenic <i>E. coli</i> (EPEC), longus (Lng) and colonization factor III (CFA/III) of enterotoxigenic <i>E. coli</i> (ETEC), T4P of <i>Salmonella enterica</i> serovar Typhi, Colonization Factor Citrobacter (CFC) of <i>Citrobacter rodentium</i>, T4P of <i>Yersinia pseudotuberculosis</i>, a ubiquitous T4P that was characterized in enterohemorrhagic <i>E. coli</i> (EHEC), and the R64 plasmid thin pilus. Finally, we highlight areas for further study.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00032023"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type I toxin-antitoxin systems in bacteria: from regulation to biological functions. 细菌中的 I 型毒素-抗毒素系统:从调节到生物功能。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-05-20 DOI: 10.1128/ecosalplus.esp-0025-2022
Selene F H Shore, Florian H Leinberger, Elizabeth M Fozo, Bork A Berghoff

Toxin-antitoxin systems are ubiquitous in the prokaryotic world and widely distributed among chromosomes and mobile genetic elements. Several different toxin-antitoxin system types exist, but what they all have in common is that toxin activity is prevented by the cognate antitoxin. In type I toxin-antitoxin systems, toxin production is controlled by an RNA antitoxin and by structural features inherent to the toxin messenger RNA. Most type I toxins are small membrane proteins that display a variety of cellular effects. While originally discovered as modules that stabilize plasmids, chromosomal type I toxin-antitoxin systems may also stabilize prophages, or serve important functions upon certain stress conditions and contribute to population-wide survival strategies. Here, we will describe the intricate RNA-based regulation of type I toxin-antitoxin systems and discuss their potential biological functions.

毒素-抗毒素系统在原核生物中无处不在,广泛分布于染色体和移动遗传因子中。毒素-抗毒素系统有几种不同的类型,但它们的共同点都是毒素活性被同源的抗毒素所阻止。在 I 型毒素-抗毒素系统中,毒素的产生受 RNA 抗毒素和毒素信使 RNA 固有结构特征的控制。大多数 I 型毒素都是小型膜蛋白,能产生多种细胞效应。虽然最初是作为稳定质粒的模块被发现的,但染色体 I 型毒素-抗毒素系统也可能稳定原生质粒,或在某些应激条件下发挥重要功能,并有助于整个种群的生存策略。在这里,我们将描述 I 型毒素-抗毒素系统基于 RNA 的复杂调控,并讨论其潜在的生物学功能。
{"title":"Type I toxin-antitoxin systems in bacteria: from regulation to biological functions.","authors":"Selene F H Shore, Florian H Leinberger, Elizabeth M Fozo, Bork A Berghoff","doi":"10.1128/ecosalplus.esp-0025-2022","DOIUrl":"10.1128/ecosalplus.esp-0025-2022","url":null,"abstract":"<p><p>Toxin-antitoxin systems are ubiquitous in the prokaryotic world and widely distributed among chromosomes and mobile genetic elements. Several different toxin-antitoxin system types exist, but what they all have in common is that toxin activity is prevented by the cognate antitoxin. In type I toxin-antitoxin systems, toxin production is controlled by an RNA antitoxin and by structural features inherent to the toxin messenger RNA. Most type I toxins are small membrane proteins that display a variety of cellular effects. While originally discovered as modules that stabilize plasmids, chromosomal type I toxin-antitoxin systems may also stabilize prophages, or serve important functions upon certain stress conditions and contribute to population-wide survival strategies. Here, we will describe the intricate RNA-based regulation of type I toxin-antitoxin systems and discuss their potential biological functions.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00252022"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcription activation in Escherichia coli and Salmonella. 大肠杆菌和沙门氏菌的转录激活。
Q1 Medicine Pub Date : 2024-12-12 Epub Date: 2024-02-12 DOI: 10.1128/ecosalplus.esp-0039-2020
Stephen J W Busby, Douglas F Browning

Promoter-specific activation of transcript initiation provides an important regulatory device in Escherichia coli and Salmonella. Here, we describe the different mechanisms that operate, focusing on how they have evolved to manage the "housekeeping" bacterial transcription machinery. Some mechanisms involve assisting the bacterial DNA-dependent RNA polymerase or replacing or remodeling one of its subunits. Others are directed to chromosomal DNA, improving promoter function, or relieving repression. We discuss how different activators work together at promoters and how the present complex network of transcription factors evolved.

在大肠杆菌和沙门氏菌中,启动子特异性激活转录本启动是一种重要的调控手段。在这里,我们描述了不同的运作机制,重点是它们是如何进化来管理 "看家 "细菌转录机制的。一些机制涉及辅助细菌的 DNA 依赖性 RNA 聚合酶,或替换或重塑其一个亚基。其他机制则针对染色体 DNA、改善启动子功能或缓解抑制。我们将讨论不同的激活因子如何在启动子上协同工作,以及目前复杂的转录因子网络是如何演变而来的。
{"title":"Transcription activation in <i>Escherichia coli</i> and <i>Salmonella</i>.","authors":"Stephen J W Busby, Douglas F Browning","doi":"10.1128/ecosalplus.esp-0039-2020","DOIUrl":"10.1128/ecosalplus.esp-0039-2020","url":null,"abstract":"<p><p>Promoter-specific activation of transcript initiation provides an important regulatory device in <i>Escherichia coli</i> and <i>Salmonella</i>. Here, we describe the different mechanisms that operate, focusing on how they have evolved to manage the \"housekeeping\" bacterial transcription machinery. Some mechanisms involve assisting the bacterial DNA-dependent RNA polymerase or replacing or remodeling one of its subunits. Others are directed to chromosomal DNA, improving promoter function, or relieving repression. We discuss how different activators work together at promoters and how the present complex network of transcription factors evolved.</p>","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":" ","pages":"eesp00392020"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636354/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139722108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition of Escherichia coli within the intestinal microbiome 肠道微生物群中大肠杆菌的营养状况
Q1 Medicine Pub Date : 2024-01-11 DOI: 10.1128/ecosalplus.esp-0006-2023
Sudhir Doranga, K. A. Krogfelt, Paul S. Cohen, Tyrrell Conway
ABSTRACT In this chapter, we update our 2004 review of “The Life of Commensal Escherichia coli in the Mammalian Intestine” (https://doi.org/10.1128/ecosalplus.8.3.1.2), with a change of title that reflects the current focus on “Nutrition of E. coli within the Intestinal Microbiome.” The earlier part of the previous two decades saw incremental improvements in understanding the carbon and energy sources that E. coli and Salmonella use to support intestinal colonization. Along with these investigations of electron donors came a better understanding of the electron acceptors that support the respiration of these facultative anaerobes in the gastrointestinal tract. Hundreds of recent papers add to what was known about the nutrition of commensal and pathogenic enteric bacteria. The fact that each biotype or pathotype grows on a different subset of the available nutrients suggested a mechanism for succession of commensal colonizers and invasion by enteric pathogens. Competition for nutrients in the intestine has also come to be recognized as one basis for colonization resistance, in which colonized strain(s) prevent colonization by a challenger. In the past decade, detailed investigations of fiber- and mucin-degrading anaerobes added greatly to our understanding of how complex polysaccharides support the hundreds of intestinal microbiome species. It is now clear that facultative anaerobes, which usually cannot degrade complex polysaccharides, live in symbiosis with the anaerobic degraders. This concept led to the “restaurant hypothesis,” which emphasizes that facultative bacteria, such as E. coli, colonize the intestine as members of mixed biofilms and obtain the sugars they need for growth locally through cross-feeding from polysaccharide-degrading anaerobes. Each restaurant represents an intestinal niche. Competition for those niches determines whether or not invaders are able to overcome colonization resistance and become established. Topics centered on the nutritional basis of intestinal colonization and gastrointestinal health are explored here in detail.
摘要 在本章中,我们更新了 2004 年对 "哺乳动物肠道中共生大肠埃希氏菌的生活"(https://doi.org/10.1128/ecosalplus.8.3.1.2)的评论,标题的改变反映了当前对 "肠道微生物组中大肠埃希氏菌的营养 "的关注。在过去二十年的早期,人们对大肠杆菌和沙门氏菌用于支持肠道定植的碳源和能量源的了解逐步加深。随着对电子供体的研究,人们对支持这些变性厌氧菌在胃肠道内呼吸的电子受体也有了更好的了解。最近的数百篇论文增加了人们对肠道共生菌和致病菌营养的了解。事实上,每种生物型或病理型都生长在不同的可用营养物质子集上,这表明共生菌定植者的继承和肠道病原体的入侵是一种机制。肠道中的营养竞争也被认为是定植抵抗的基础之一,在这种情况下,定植菌株会阻止挑战者的定植。在过去十年中,对纤维和粘蛋白降解厌氧菌的详细研究大大加深了我们对复杂多糖如何支持数百种肠道微生物群的理解。现在很清楚,通常不能降解复杂多糖的兼性厌氧菌与厌氧降解菌共生。这一概念导致了 "餐厅假说",它强调大肠杆菌等兼性细菌作为混合生物膜的成员在肠道中定植,并通过与降解多糖的厌氧菌交叉觅食获得生长所需的糖分。每家餐厅都代表着一个肠道生态位。对这些生态位的争夺决定了入侵者是否能够克服定植阻力并站稳脚跟。这里将详细探讨以肠道定植和肠道健康的营养基础为中心的主题。
{"title":"Nutrition of Escherichia coli within the intestinal microbiome","authors":"Sudhir Doranga, K. A. Krogfelt, Paul S. Cohen, Tyrrell Conway","doi":"10.1128/ecosalplus.esp-0006-2023","DOIUrl":"https://doi.org/10.1128/ecosalplus.esp-0006-2023","url":null,"abstract":"ABSTRACT In this chapter, we update our 2004 review of “The Life of Commensal Escherichia coli in the Mammalian Intestine” (https://doi.org/10.1128/ecosalplus.8.3.1.2), with a change of title that reflects the current focus on “Nutrition of E. coli within the Intestinal Microbiome.” The earlier part of the previous two decades saw incremental improvements in understanding the carbon and energy sources that E. coli and Salmonella use to support intestinal colonization. Along with these investigations of electron donors came a better understanding of the electron acceptors that support the respiration of these facultative anaerobes in the gastrointestinal tract. Hundreds of recent papers add to what was known about the nutrition of commensal and pathogenic enteric bacteria. The fact that each biotype or pathotype grows on a different subset of the available nutrients suggested a mechanism for succession of commensal colonizers and invasion by enteric pathogens. Competition for nutrients in the intestine has also come to be recognized as one basis for colonization resistance, in which colonized strain(s) prevent colonization by a challenger. In the past decade, detailed investigations of fiber- and mucin-degrading anaerobes added greatly to our understanding of how complex polysaccharides support the hundreds of intestinal microbiome species. It is now clear that facultative anaerobes, which usually cannot degrade complex polysaccharides, live in symbiosis with the anaerobic degraders. This concept led to the “restaurant hypothesis,” which emphasizes that facultative bacteria, such as E. coli, colonize the intestine as members of mixed biofilms and obtain the sugars they need for growth locally through cross-feeding from polysaccharide-degrading anaerobes. Each restaurant represents an intestinal niche. Competition for those niches determines whether or not invaders are able to overcome colonization resistance and become established. Topics centered on the nutritional basis of intestinal colonization and gastrointestinal health are explored here in detail.","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":"3 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The rise, fall, and resurgence of phage therapy for urinary tract infection 噬菌体疗法治疗尿路感染的兴衰与复苏
Q1 Medicine Pub Date : 2024-01-11 DOI: 10.1128/ecosalplus.esp-0029-2023
J. Zulk, K. Patras, A. Maresso
ABSTRACT In the face of rising antimicrobial resistance, bacteriophage therapy, also known as phage therapy, is seeing a resurgence as a potential treatment for bacterial infections including urinary tract infection (UTI). Primarily caused by uropathogenic Escherichia coli, the 400 million UTI cases annually are major global healthcare burdens and a primary cause of antibiotic prescriptions in the outpatient setting. Phage therapy has several potential advantages over antibiotics including the ability to disrupt bacterial biofilms and synergize with antimicrobial treatments with minimal side effects or impacts on the microbiota. Phage therapy for UTI treatment has shown generally favorable results in recent animal models and human case reports. Ongoing clinical trials seek to understand the efficacy of phage therapy in individuals with asymptomatic bacteriuria and uncomplicated cystitis. A possible challenge for phage therapy is the development of phage resistance in bacteria during treatment. While resistance frequently develops in vitro and in vivo, resistance can come with negative consequences for the bacteria, leaving them susceptible to antibiotics and other environmental conditions and reducing their overall virulence. “Steering” bacteria toward phage resistance outcomes that leave them less fit or virulent is especially useful in the context of UTI where poorly adherent or slow-growing bacteria are likely to be flushed from the system. In this article, we describe the history of phage therapy in treating UTI and its current resurgence, the state of its clinical use, and an outlook on how well-designed phage therapy could be used to “steer” bacteria toward less virulent and antimicrobial-susceptible states.
摘要 面对抗菌药耐药性的不断上升,噬菌体疗法(又称噬菌体疗法)作为一种潜在的治疗细菌感染(包括尿路感染)的方法正在重新兴起。尿路感染主要由尿路致病性大肠杆菌引起,每年有 4 亿尿路感染病例,是全球医疗保健的主要负担,也是门诊抗生素处方的主要原因。与抗生素相比,噬菌体疗法有几个潜在的优势,包括能破坏细菌生物膜,与抗菌治疗协同作用,且副作用或对微生物群的影响最小。在最近的动物模型和人类病例报告中,噬菌体疗法治疗UTI的效果普遍良好。正在进行的临床试验旨在了解噬菌体疗法对无症状菌尿和无并发症膀胱炎患者的疗效。噬菌体疗法可能面临的一个挑战是在治疗过程中细菌产生噬菌体抗药性。虽然抗药性经常在体外和体内产生,但抗药性会给细菌带来负面影响,使其容易受到抗生素和其他环境条件的影响,并降低其整体毒力。将细菌 "引导 "至噬菌体产生抗药性的结果,降低它们的适应性或毒力,这对UTI 尤为有用,因为在UTI 中,粘附性差或生长缓慢的细菌很可能会被冲出系统。在本文中,我们将介绍噬菌体疗法治疗UTI的历史及其目前的复苏情况、临床应用现状,并展望如何利用精心设计的噬菌体疗法将细菌 "引导 "至毒力较低和对抗菌素敏感的状态。
{"title":"The rise, fall, and resurgence of phage therapy for urinary tract infection","authors":"J. Zulk, K. Patras, A. Maresso","doi":"10.1128/ecosalplus.esp-0029-2023","DOIUrl":"https://doi.org/10.1128/ecosalplus.esp-0029-2023","url":null,"abstract":"ABSTRACT In the face of rising antimicrobial resistance, bacteriophage therapy, also known as phage therapy, is seeing a resurgence as a potential treatment for bacterial infections including urinary tract infection (UTI). Primarily caused by uropathogenic Escherichia coli, the 400 million UTI cases annually are major global healthcare burdens and a primary cause of antibiotic prescriptions in the outpatient setting. Phage therapy has several potential advantages over antibiotics including the ability to disrupt bacterial biofilms and synergize with antimicrobial treatments with minimal side effects or impacts on the microbiota. Phage therapy for UTI treatment has shown generally favorable results in recent animal models and human case reports. Ongoing clinical trials seek to understand the efficacy of phage therapy in individuals with asymptomatic bacteriuria and uncomplicated cystitis. A possible challenge for phage therapy is the development of phage resistance in bacteria during treatment. While resistance frequently develops in vitro and in vivo, resistance can come with negative consequences for the bacteria, leaving them susceptible to antibiotics and other environmental conditions and reducing their overall virulence. “Steering” bacteria toward phage resistance outcomes that leave them less fit or virulent is especially useful in the context of UTI where poorly adherent or slow-growing bacteria are likely to be flushed from the system. In this article, we describe the history of phage therapy in treating UTI and its current resurgence, the state of its clinical use, and an outlook on how well-designed phage therapy could be used to “steer” bacteria toward less virulent and antimicrobial-susceptible states.","PeriodicalId":11500,"journal":{"name":"EcoSal Plus","volume":"11 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
EcoSal Plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1